#5-39E. Moving Beyond Opioids: A Holistic Approach to Pain in Inflammatory Arthritis (Rheumatology, 2026)

How often do we reflexively prescribe long-term opioids for patients experiencing persistent pain from inflammatory arthritis, despite a striking lack of supportive clinical evidence? The new 2026 British Society for Rheumatology guideline addresses this clinical challenge by introducing a comprehensive, life-course framework that prioritizes non-pharmacological modalities—including physical exercise, occupational therapy, sleep restoration, and psychological support—over a heavy reliance on traditional analgesics. The most significant and actionable clinical point highlighted in this update is the emphasis on actively tapering ineffective, long-term analgesics and neuromodulators through structured shared decision-making. However, when critically appraising this document, clinicians must remain mindful that a substantial portion of these recommendations relies on low-quality evidence, demonstrating an urgent need for definitive, high-quality randomized controlled trials. For practicing physicians, this guideline serves as a vital clinical roadmap, prompting a paradigm shift from routine drug prescribing to collaborative, multidisciplinary pain care that directly optimizes patient-centered goals, clinical safety, and long-term quality of life.Citation: Ian C. Scott, et al. The 2026 British Society for Rheumatology guideline for pain management in people with inflammatory arthritis. Rheumatology. 2026. DOI: 10.1093/rheumatology/keag320

URL: https://doi.org/10.1093/rheumatology/keag320

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.